BMC Cancer, 19:901. BioMed Central BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019) De Haan, R, Van Werkhoven, E, Peulen, H M U, Sonke, G S, Elkhuizen, P, Van Den Brekel, M W M, Tesselaar, M E T, Vens, C, Schellens, J H M, Van Triest, B & Verheij, M 2019, ' Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib ', BMC Cancer, vol. 19, no. 1, 901 . https://doi.org/10.1186/s12885-019-6121-3 BMC Cancer, 19(1). BioMed Central BMC Cancer, 19 BMC Cancer, 19(1):901. BioMed Central BMC cancer, 19(1):901. BioMed Central BMC Cancer
Van den Heuvel, M M, Tensen, C P, van As, J H, Van den Berg, T K, Fluitsma, D M, Dijkstra, C D, Döpp, E A, Droste, A, Van Gaalen, F A, Sorg, C, Högger, P & Beelen, R H 1999, ' Regulation of CD 163 on human macrophages : cross-linking of CD163 induces signaling and activation ', Journal of Leukocyte Biology, vol. 66, no. 5, pp. 858-66 .